SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-261966
Filing Date
2020-10-02
Accepted
2020-10-02 07:53:01
Documents
12
Period of Report
2020-10-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d33191d8k.htm   iXBRL 8-K 30820
  Complete submission text file 0001193125-20-261966.txt   160610

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20201001.xsd EX-101.SCH 3057
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20201001_lab.xml EX-101.LAB 19656
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20201001_pre.xml EX-101.PRE 12306
5 EXTRACTED XBRL INSTANCE DOCUMENT d33191d8k_htm.xml XML 3645
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 201218076
SIC: 2836 Biological Products, (No Diagnostic Substances)